Published in J Nephrol on December 03, 2001
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS (2008) 1.30
HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol (2004) 1.19
HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study. BMC Nephrol (2003) 1.05
Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc (2014) 1.01
Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis (2007) 0.91
The pharmacologic management of insomnia in patients with HIV. J Clin Sleep Med (2009) 0.87
Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene. Adv Chronic Kidney Dis (2010) 0.83
APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol (2013) 0.77
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi. PLoS One (2012) 0.75
Interstitial nephritis caused by HIV infection by itself: a case report. Int J Gen Med (2016) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis (2000) 1.54
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum (1998) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11
Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol (2001) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int (1997) 1.07
Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol (1999) 1.02
Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2001) 1.02
Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol (2001) 1.02
Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01
Renal transplantation in end-stage sickle cell nephropathy. Transplantation (1999) 1.01
Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis (2001) 1.00
Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis (2001) 0.99
Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis (1999) 0.95
The United States Renal Data System's 1991 annual data report: an introduction. Am J Kidney Dis (1991) 0.94
Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol (1999) 0.93
Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med (1984) 0.92
Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int (1990) 0.92
Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol (2001) 0.92
Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int (2000) 0.92
Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 0.91
Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1992) 0.90
Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. Transpl Infect Dis (2002) 0.89
Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. Kidney Int (1999) 0.88
Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data. Am J Transplant (2007) 0.88
Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol (1985) 0.87
Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol (1983) 0.87
Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic. Clin Nephrol (2001) 0.86
Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol (1987) 0.86
Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis (2000) 0.86
A critical examination of trends in outcomes over the last decade. Am J Kidney Dis (1998) 0.86
Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol (2001) 0.85
Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes. Clin Nephrol (2003) 0.85
Potential causes and pathogenesis in autosomal dominant polycystic kidney disease. Nephron (1983) 0.84
Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol (2001) 0.84
Analysis of the quantitative relationship between anemia and chronic renal failure. Am J Med Sci (1989) 0.82
The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol (2001) 0.81
Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study. Am J Kidney Dis (1997) 0.81
Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis (1999) 0.80
Characteristics and treatment of patients not reusing dialyzers in reuse units. Am J Kidney Dis (2000) 0.80
Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years. Am J Kidney Dis (1990) 0.79
Removal of subepithelial immune complexes with excess unaltered or cationic antigen. Kidney Int (1987) 0.79
[Practical guidelines for the management of Ebola infected patients in the field]. Med Trop (Mars) (2004) 0.78
Splanchnic volume, not flow rate, determines peritoneal permeability. ASAIO Trans (1990) 0.77
Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron (2001) 0.77
Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing (1995) 0.77
Growth rates in pediatric dialysis patients and renal transplant recipients. Am J Kidney Dis (1997) 0.76
The role of pretransplant time and therapy on kidney graft survival. Clin Transpl (1989) 0.75
The United States Renal Data System's 1990 Annual Data Report: an introduction. Am J Kidney Dis (1990) 0.75
Recent trends in cadaveric renal transplantation. Clin Transpl (1990) 0.75
Analyzing process variation in chart review using a networked spreadsheet application in the Walter Reed Army Medical Center Nephrology Clinic. Mil Med (2001) 0.75
The Walter Reed Army Medical Center outpatient infusion service: lessons for managing health care change at the local level. Mil Med (1999) 0.75